Pheiron GmbH

Pheiron builds an AI-native platform that unifies population-scale human data (genetics, epidemiology, and clinical data) to generate quantitative evidence for drug development. The focus is on modeling disease mechanisms, patient subgroups, and disease progression to support decisions in target discovery and clinical programs. Target users include biotech and pharma companies as well as research teams.